About Vitadio
Vitadio is a company based in Prague (Czechia) founded in 2017 by Bolek Kristian, Jan Somvarsky, Lucie Kovarova, Lenka Rohryova, and Ondrej Kulatka. Vitadio has raised $3.34 million across 1 funding round from investors including Theras Group. Vitadio offers products and services including Vitadio App and Digital Therapy Program. Vitadio operates in a competitive market with competitors including BeatO, Glooko, Fitterfly, Health2Sync and Dr. Diary Co, among others.
- Headquarter Prague, Czechia
- Founders Bolek Kristian, Jan Somvarsky, Lucie Kovarova, Lenka Rohryova, Ondrej Kulatka
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vitadio Sro
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.34 M (USD)
in 1 rounds
-
Latest Funding Round
$3.34 M (USD), Series A
Jul 24, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vitadio
Vitadio offers a comprehensive portfolio of products and services, including Vitadio App and Digital Therapy Program.
AI-driven tool for managing type 2 diabetes via personalized lifestyle changes.
Evidence-based program for reversing insulin resistance through habit building.
People of Vitadio
Unlock access to complete
Funding Insights of Vitadio
Vitadio has successfully raised a total of $3.34M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.34 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.3M
-
First Round
First Round
(24 Jul 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Series A - Vitadio | Valuation | Theras Group |
|
Investors in Vitadio
Vitadio has secured backing from 1 investor. Prominent investors backing the company include Theras Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Develops medical technologies for diabetes, chronic pain, and weight management solutions.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vitadio
Financial Statements - Vitadio
Vitadio Comparisons
Competitors of Vitadio
Vitadio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeatO, Glooko, Fitterfly, Health2Sync and Dr. Diary Co, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Smartphone-enabled glucometers and diabetes management apps are provided.
|
|
| domain | founded_year | HQ Location |
Diabetes management is enabled via glucose meters and mobile apps.
|
|
| domain | founded_year | HQ Location |
A mobile app is offered for managing multiple chronic diseases.
|
|
| domain | founded_year | HQ Location |
Provider of an app for tracking blood glucose level
|
|
| domain | founded_year | HQ Location |
Provider of app for diabetes management
|
|
| domain | founded_year | HQ Location |
Offers cloud-based SaaS for diabetes management and insulin dosing in hospitals.
|
Latest news on Vitadio
Frequently Asked Questions about Vitadio
Vitadio was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Vitadio is headquartered in Prague, Czechia.
Vitadio is a funded company, having raised a total of $3.34M across 1 funding round to date. The company's 1st funding round was a Series A of $3.34M, raised on Jul 24, 2023.
Vitadio was founded in 2017 in Prague, Czech Republic, as a health technology company focused on diabetes care. An online platform is operated to assist patients in managing weight, controlling glucose levels, and reducing blood sugar and HbA1c. Information on treatments and habit-building strategies is delivered, with support from personal dietitians available via chat and video consultations. Operations target improved quality of life for diabetic individuals across the region.
Vitadio offers Vitadio App and Digital Therapy Program.
Vitadio has 1 investor. Key investors include Theras Group.